Published in Immunology on March 01, 1978
The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system. J Exp Med (1961) 3.81
The effect of neuraminidase on the fate of transfused lymphocytes. J Exp Med (1969) 2.91
An alteration in tumor histocompatibility induced by neuraminidase. Transplantation (1967) 2.63
Viral and bacterial neuraminidases. Curr Top Microbiol Immunol (1972) 1.79
[Studies on bound carbohydrates in isolated plasma proteins]. Biochem Z (1958) 1.52
Neuraminidase, sialic acids, and cell interactions. J Natl Cancer Inst (1973) 1.38
The requirement for membrane sialic acid in the stimulation of superoxide production during phagocytosis by human polymorphonuclear leukocytes. J Exp Med (1976) 1.35
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
Enhancement of in vitro lymphocyte response by neuraminidase. Clin Exp Immunol (1973) 1.16
Sialic acids (N,7-O-diacetylneuraminic acid and N-acetylneuraminic adcid) in Escherichia coli. II. Their presence on the cell wall surface and relationship to K antigen. J Bacteriol (1961) 1.13
The effect of neuraminidase on the immunogenicity of the Landschütz ascites tumour: site and mode of action. Br J Cancer (1968) 1.12
Some effects of neuraminidase on the in vitro interactions between spleen and mastocytoma (P815) cells. Int J Cancer (1971) 1.00
The mechanism of phagocytosis. J Reticuloendothel Soc (1976) 0.94
Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages. Proc Soc Exp Biol Med (1968) 0.90
Immunogenicity of leukemia L1210 cells after neuraminidase treatment. J Natl Cancer Inst (1972) 0.87
Regression of spontaneous mammary tumors in dogs after injection of neuraminidase-treated tumor cells. Int J Cancer (1975) 0.82
Effect of neuraminidase on the rat one-way mixed lymphocyte interaction. Immunol Commun (1973) 0.81
Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens. Immunology (1978) 0.80
Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med (2001) 7.46
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol (1999) 2.84
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. Immunology (1969) 1.93
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer (1997) 1.86
Endovenous treatment of the greater saphenous vein with a 940-nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser-generated steam bubbles. J Vasc Surg (2002) 1.82
A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol (1997) 1.78
Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77
Antibody cross-linking as a factor in immunity to cholera in infant mice. J Infect Dis (1975) 1.61
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer (2001) 1.52
[Granuloma anulare disseminatum as a rare side effect of allopurinol]. Hautarzt (1995) 1.51
Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med (1994) 1.46
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the intestines of infant mice and the role of antibody. Aust J Exp Biol Med Sci (1975) 1.46
Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells. J Immunol (1997) 1.46
Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res (2001) 1.43
[Adjuvant therapy of pemphigus vulgaris and pemphigus foliaceus with intravenous immunoglobulins]. Hautarzt (1998) 1.39
Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol (1983) 1.35
Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J Nucl Med (1988) 1.32
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32
Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer (1999) 1.31
Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol (1997) 1.30
Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis (1971) 1.27
IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol (1995) 1.26
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the gastrointestinal tract of adult mice. Aust J Exp Biol Med Sci (1975) 1.24
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol (1998) 1.24
Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol (1997) 1.22
Protection against cholera. A bactericidal mechanism on the mucosal surface of the small intestine of mice. Aust J Exp Biol Med Sci (1975) 1.20
Possible synthesis of pregnancy-'specific' beta-1-glycoprotein (sp1) and placenta-'specific' tissue proteins (PP10,PP12) by human and cynomolgus monkey leukocytes. Acta Haematol (1981) 1.18
The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum. Aust J Exp Biol Med Sci (1971) 1.17
Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther (2000) 1.16
Inhibition of the mixed leukocyte culture (MLC) by proteins: mechanism and specificity of the reaction [proceedings]. Z Immunitatsforsch Immunobiol (1976) 1.14
Morphological observations on the contact-induced lysis of target cells. Eur J Immunol (1973) 1.13
The electroencephalogram after alcohol administration in high-risk men and the development of alcohol use disorders 10 years later. Arch Gen Psychiatry (1996) 1.13
Evidence for an endothelial cell dysfunction in association with Behçet's disease. Thromb Res (1984) 1.13
Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res (1996) 1.10
Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer (2000) 1.06
Alcoholism and depression in adopted-out daughters of alcoholics. Arch Gen Psychiatry (1977) 1.05
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol (2000) 1.01
The behaviour of lymphocytes in the process of target cell destruction in vitro. Exp Cell Res (1968) 1.01
Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet (1997) 0.99
Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis. Clin Exp Immunol (1988) 0.99
The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes. Immunology (1975) 0.99
Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Dermatol Res (1992) 0.98
Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol (1997) 0.98
Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol (2001) 0.98
Modulation of suppressor mechanisms in allergic contact dermatitis: 1. Effect of C. parvum on the induction phase of contact allergy. J Invest Dermatol (1981) 0.98
Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection. Clin Exp Immunol (1979) 0.98
Graft reaction in tissue culture by normal rat lymphocytes. Transplant Proc (1969) 0.98
IQ as a protective factor for subjects at high risk for antisocial behavior. J Consult Clin Psychol (1988) 0.97
Cholera toxin induced redistribution of sialoglycolipid receptor at the lymphocyte membrane. FEBS Lett (1976) 0.97
Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. J Gene Med (2000) 0.96
The influence of (+/-)-15-deoxyspergualin on experimental transplantation and its immunopharmacological mode of action. Behring Inst Mitt (1986) 0.96
Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol (2000) 0.96
Thermal damage of the inner vein wall during endovenous laser treatment: key role of energy absorption by intravascular blood. Dermatol Surg (2002) 0.96
Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol (2003) 0.95
Detection of sensitized human blood lymphocytes by agglutination with basic peptides: a possible test for malignant disease. Br J Cancer (1977) 0.95
Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol (1998) 0.94
Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. J Allergy Clin Immunol (1999) 0.93
Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int J Cancer (1985) 0.93
Interferon inhibits the suppressor T cell response of delayed-type hypersensitivity. Nature (1982) 0.92
Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy. Gene Ther (2000) 0.91
Activation of murine epidermal TCR-gamma delta+ T cells by keratinocytes treated with contact sensitizers. J Immunol (1995) 0.91
Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers, tolerogens and irritants. Exp Dermatol (1994) 0.91
Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity. Immunology (1986) 0.90
Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol (1995) 0.90
Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity. Gene Ther (2002) 0.90
Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin. Transplant Proc (1990) 0.90
Haematological effects of rhGM-CSF in dogs exposed to total-body irradiation with a dose of 2.4 Gy. Int J Radiat Biol (1992) 0.89
A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas. Cancer Immunol Immunother (1986) 0.89
Mouse langerhans cells differentially express an activated T cell-attracting CC chemokine. J Invest Dermatol (1999) 0.89
Effect of the new immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteria. Int J Immunopharmacol (1991) 0.89
15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE). Agents Actions (1991) 0.89
Cytotoxicity of allogeneic lymphocytes sensitized against H-2 antigens in vitro. Exp Cell Res (1971) 0.88
Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J Invest Dermatol (2000) 0.88
A prospective study of young men at high risk for alcoholism. Social and psychological characteristics. Arch Gen Psychiatry (1986) 0.88
Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis. Drugs Exp Clin Res (1991) 0.88
Discovery of antitoxins and development of antibody preparations for clinical uses from 1890 to 1990. Mol Immunol (1991) 0.87
Infrequent early recanalization of greater saphenous vein after endovenous laser treatment. J Vasc Surg (2003) 0.87
Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation. Br J Cancer (1992) 0.87
In-vivo phagocytosis: enhancement of bacterial clearance by native and enzyme-treated immunoglobulins. Immunobiology (1981) 0.87
Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon. J Immunol (1984) 0.87
Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. Arch Dermatol Res (2000) 0.87
Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys. Int J Cell Cloning (1990) 0.86
The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol (2001) 0.86
A prospective study of young men at high risk for alcoholism: school behavior and achievement. J Stud Alcohol (1985) 0.86
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 1st communication: synthesis and structure-activity relationships. Arzneimittelforschung (1989) 0.86
The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab]. Klin Wochenschr (1983) 0.85
Identification and induction of human keratinocyte-derived IL-12. J Clin Invest (1994) 0.85
A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Hybridoma (1991) 0.85
Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg (2002) 0.85